Tumor necrosis factor alpha alters Na+-K+ ATPase activity in rat cardiac myocytes: Involvement of NF-κB, AP-1 and PGE2

Life Sciences

Volumn 80, Issue 2, 2006, Pages 173-180

  Skayian, Yester ^a   Kreydiyyeh, Sawsan Ibrahim ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cytokines; Myocytes; Na K pump; NF B AP 1; PGE2

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); CURCUMIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; PROSTAGLANDIN E2; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART VENTRICLE; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT;

ANIMALS; CURCUMIN; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOMETHACIN; MALE; MYOCYTES, CARDIAC; NA(+)-K(+)-EXCHANGING ATPASE; NF-KAPPA B; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; THIOCARBAMATES; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 33845224011     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.08.037     Document Type: Article

References (44)

1. Abramovitz M., Adam M., Boie Y., Carriere M., Denis D., Lamontagne C., et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochimica et Biophysica Acta 1483 (2000) 285-293
2. Barnes P.J., and Karin M. Nuclear factor-κB A pivotal transcription factor in chronic inflammatory disease. The New England Journal of Medicine 336 (1997) 1066-1071
3. + regulation in cardiac myocytes. Cardiovascular Research 57 (2003) 897-912
4. Blanco G., and Mercer R.W. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. American Journal of Physiology 275 (1998) F633-F650
5. Bos C.L., Richel D.J., Ritsema T., Peppelenbosch M.P., and Versteeg H.H. Prostanoids and prostanoid receptors in signal transduction. The International Journal of Biochemistry & Cell Biology 36 (2004) 1187-1205
6. Bundgaard H., and Kjeldsen K. Human myocardial Na, K-ATPase concentration in heart failure. Molecular and Cellular Biochemistry 163-164 (1996) 277-283
7. Damirin A., Tomura H., Komachi M., Tobo M., Sato K., Mogi C., Nochi H., Tamoto K., and Okajima F. Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells. Molecular Pharmacology 67 (2005) 1177-1185
8. Dibbs Z., Kurrelmeyer K., Kalra D., Seta Y., Wang F., Bozkurt B., Baumgarten G., Sivasubramanian N., and Mann D.L. Cytokines in heart failure: pathogenetic mechanisms and potential treatment. Proceedings of the Association of American Physicians 111 (1999) 423-428
9. Diehl A.M., Yin .M., Fleckenstein J., Yang S.Q., Lin H.Z., Brenner D.A., Westwick J., Bagby G., and Nelson S. Tumor necrosis factor-alpha induces c-Jun during the regenerative response to liver injury. American Journal of Physiology 267 (1994) G552-G561
10. Dostanic I., Schultz J., Lorenz J.N., and Lingrel J.B. The alpha 1 isoform of Na, K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heart. Journal of Biological Chemistry 279 (2004) 54053-54061
11. Ferreri N.R., McGiff J.C., Vio C.P., and Carroll M.A. TNFα regulates renal COX-2 in the rat thick ascending limb (TAL). Thrombosis Research 110 (2003) 277-280
12. Geering K. Na+/K+-ATPase. Current Opinion in Nephrology Hypertension 5 (1997) 434-439
13. Geering K., Beggah A., Good P., Girardet S., Roy S., Schaer D., and Jaunin P. Oligomerization and maturation of Na, K-ATPase: functional interaction of the cytoplasmic NH2 terminus of the beta subunit with the alpha subunit. Journal of Cell Biology 133 (1996) 1193-1204
14. Glitsch H.G. Electrophysiology of the sodium-potassium ATPase in cardiac cells. Physiological Reviews 81 4 (2001) 1791-1826
15. Hata A.N., and Breyer R.M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacology & Therapeutics 103 (2004) 147-166
16. 2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation. American Journal of Physiology 259 (1990) F318-F325
17. Hilal-Dandan R., Kanter J.R., and Brunton L.L. Characterization of G-protein signaling in ventricular myocytes from the adult mouse heart: differences from rat. Journal of Molecular and Cellular Cardiology 32 (2000) 1211-1221
18. Hohlfeld T., Meyer-Kirchrath J., Vogel Y.C., and Schror K. Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart. Journal of Molecular and Cellular Cardiology 32 (2000) 285-296
19. Holycross B.J., and Radin M.J. Cytokines in heart failure: potential interactions with angiotensin II and leptin. Molecular Interventions 2 (2002) 424-427
20. Kang G., Kong P.J., Yuh Y.J., Lim S.Y., Yim S.V., Chun W., and Kim S.S. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappa bindings in BV2 microglial cells. Journal of Pharmacological Sciences 94 (2004) 325-328
21. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Current Opinion in Cell Biology 2 (1997) 240-246
22. + ATPase activity and protein expression in cardiac myocytes. Cytokine 26 (2004) 1-8
23. Mann D.L., and Young J.B. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 105 (1994) 897-904
24. McDonnough A.A., Velotta J.B., Schwinger R.H., Philipson K.D., and Fareley R.A. The cardiac sodium pump: structure and function. Basic Research in Cardiology 97 Supple 1 (2002) 119-124
25. +-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Bioscience Reports 20 (2000) 51-91
26. Muller-Ehmsen J., McDonough A.M., Farley R.A., and Schwinger R.H.G. Sodium pump isoform expression in heart failure: implication for treatment. Basic Research in Cardiology 97 Suppl 1 (2002) I/25-I/30
27. Nakao S., Ogtata Y., Shimizu E., Yamazaki M., Furuyama S., and Sugiya H. Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NF kappa B in human gingival fibroblasts. Molecular and Cellular Biochemistry 238 (2002) 11-18
28. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiological Reviews 79 (1999) 1193-1226
29. Niwa M., Kozawa O., Matsuno H., Kanamori Y., Hara A., and Uematsu T. Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production. Life Sciences 66 (2000) 245-256
30. Nozaki N., Yamaguchi S., Shirakabe M., Nakamura H., and Tomoike H. Solube tunor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Japanese Circulation Journal 61 (1997) 657-664
31. Osawa Y., Banno Y., Nagaki M., Brenner D.A., Naiki T., Nozawa Y., Nakashima S., and Moriwaki H. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. Journal of Immunology 167 (2001) 173-180
32. + ATPase in the dilated cardiomyopathic hamster. Cell and Molecular Biology 47 (2001) 255-260
33. 2 production and bone resorption in mouse calvarial bone cells. International Journal of Biochemistry and Cell Biology 36 (2004) 2270-2280
34. Pettus B.J., Kitatani K., Chalfant C.E., Taha T.A., Kawamori T., Bielawski J., Obeid L.M., and Hannun Y.A. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Molecular Pharmacology 68 (2005) 330-335
35. ++ exchanger protein levels in human heart failure. Circulation 99 (1999) 2105-2112
36. Sernka T.J., Rood R.P., Mah M.Y., and Tseng C.H. Antiabsorptive effects of 16,16 dimethyl prostaglandin E2 in isolated rat colon. Prostaglandins 23 (1982) 411-426
37. Smith N.P., and Crampin E.J. Development of models of active ion transport for whole-cell modelling: cardiac sodium-potassium pump as a case study. Progress in Biophysics and Molecular Biology 85 (2004) 387-405
38. +-ATPase. Biochimica et Biophysica Acta 988 (1989) 185-220
39. Taussky H.H., and Shorr E. Microcolorimetric method for determination of inorganic phosphorous. Journal of Biological Chemistry 202 (1953) 675-685
40. Therien A.G., and Blostein R. Mechanisms of sodium pump regulation. American Journal of Physiology- Cell Physiology 279 (2000) C541-C566
41. Van Empel V.P., and De Windt L.J. Myocyte hypertrophy and apoptosis: a balancing act. Cardiovascular Research 63 (2004) 487-499
42. Xia P., Wang L., Gamble J.R., and Vadas M.A. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. Journal of Biological Chemistry 274 (1999) 34499-34505
43. Xiao C.Y., Yuhki K., Hara A., Fujino T., Kuriyama S., Yamada T., Takayama K., Takahata O., Karibe H., Taniguchi T., Narumiya S., and Ushikubi F. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation 109 (2004) 2462-2468
44. Yokoyama T., Vaca L., Rossen R.D., Durante W., Hazarika P., and Mann D.L. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. Journal of Clinical Investigation 92 (1993) 2303-2312